Trulstech ("the Company") (incorporated in Sweden
& Australia) has developed all the world-wide rights in an exciting, multi-award
winning and extremely environmentally friendly "family" of absolutely toxic-free
fire/flame retardants for application to various commercial products/materials.
The brand name of the absolutely toxic-free fire/flame retardants is MHE®.
The Company has established the UK company - Biomimetic Technology Ltd - to become the MHE® hub company - with mission to establish MHE® globally, by selling national MHE® product applications and/or MHE® legal rights to small and mid-sized material manufacturers of polymer, plastic and fibre materials, synthetic as well as natural.
Material manufacturers that are interested of increasing their market shares, by offering toxic-free products.
Today, Biomimetic is the solely owner of the former UK MHE® licensee company - Yaaparra Ltd - www.yaaparra.com
The national European MHE® legal rights, strongly limited to Europe only (including the former USSR), have been
sold to the Swedish listed company named Deflamo AB.
This Executive Summary has been prepared by the Company as a "preliminary
document" for parties, potentially interested of purchasing national MHE® product application licenses or MHE® legal rights, related to geographical territories outside Europe.
"Molecular Heat Eater®" [MHE®] comprises complete outstanding
family of cost-effective, absolutely toxic-free, eco-friendly and biodegradable
fire/flame retardant products, developed on low carbon sustainability
Patents have been applied for throughout the world.
Most fire/flame retardants in use today contain many harmful chemicals that are inert materials.
Inert materials are not bound to the host material in treatment. Inert materials easily migrate from treated host material, due to impact of mechanical forces (vibrations), and escape by airborne particles, polluting the environment including human blood and spine fluid.
Upon combustion these harmful inert chemicals release toxic gases that can kill or cause severe respiratory injuries to humans. These inert chemicals will frequently have a negative impact on human genes, which will affect future generations.
Scientific work proves that the harmful inert chemical fire/flame retardant additives are stored in human fat cells (lipids), with an impact on the human hormone production.
Many different studies prove that the harmful inert chemical fire/flame retardant additives found in women blood, cause an increased oestrogen production.
Increased oestrogen production initiate the human puberty much earlier in life, science says.
Today many girls begin their puberty as early as from 7-12 years. That seems to depend on a detected increased oestrogen production concerning young girls.
Another thing worth noticing is that women breast growth seem to be affected by the increased oestrogen production, as well.
It is known that an increased oestrogen production even increases the risk of breast cancer to occur.
Clinic studies regarding pregnant women and their breast milk prove the existence of high doses of the harmful inert chemical fire/flame retardant additives in breast milk.
In other words, the harmful inert chemical fire/flame retardant additives are transferred to the newly born babies without knowing what health-risk that might generate for the babies in future.
This is NOT the case with the absolutely toxic-free "MHE®" which
family of fire/flame retardants only contain food grade chemicals (in approved
quantities and concentrations) of a type found in daily foodstuffs,
e.g., grapes, fruit and bread.
The products are based on foodstuffs which have been consumed by humans
for thousands of years without any negative impact on health or environment.
The fire/flame retardants are marketed under the brand name MHE®
METHOD - THE TECHNICAL VALUE
Biomimicry or biomimetics comes from the Greek words bios, meaning
life, and mimesis, meaning to imitate. In other words, it is the adoption
of nature and its models, systems, processes, and elements to adapt
to solve human problems.
MHE® is a prime example of Biomimetics.
By the application of intellectual and practical know-how concerning
how to handle and control the ingoing parameters - in terms of proton
donators, volatile cat-ions, non-flammable gas, carbon sources, pH etc.,
- each one of the fire/flame retardant products is individually composed
to meet each polymer, plastic or fibre materials requirement to achieve
the relevant required fire safety standard.
THE CURRENT POSITION WITH MHE®
In July 2011 some national MHE® Patents - strongly limited to the
geographical territory of Europe including the former USSR - were sold
to the Swedish listed company Deflamo AB.
Deflamo AB is limited to produce, market and sell MHE® products
only within Europe and only under the brand name Apyrum®.
Deflamo AB is under no circumstances allowed to grant licenses to a
third party operating outside Europe.
MHE® products have received international prestigious awards every
year since December 2003.
- Environmental Innovation Scandinavia, 2003
- Seoul International Innovation Fair [SIIF], 2004
- Delta Forum in Shanghai, 2005
- BBC World Challenge, 2006
- UNEP Technical Awards, 2007
- UNEP Nature 100 Best, 2008
- Global Awards, 2009
- Seoul International Innovation Fair [SIIF], 2010
- Energy Globe Awards 2011
- International Innovation Exhibition in Kunshan (China), 2012
- 5th Fajr International Inventions & Innovations Exhibition 2013
[FINEX] in Tehran (Iran)
To receive a brief summary of MHE® - please kindly visit Internet and the following website
Note: Biomimetic Technology Ltd - the MHE® HUB company - owns 100% of the UK company Yaaparra Ltd.
WHY MHE® - THE NON-TOXIC FIRE/FLAME RETARDANT?
Worldwide, fires are the 4th leading cause of accidental death.
In the US alone fires take more than 3,000 lives per year.
In the western industrialized world the figures are estimated to be
about 10 times that.
14% of infant deaths in the western industrialized world are due to
The scale of accidents and deaths caused by fire in developing countries
may be even more.
The number of humans injured by fire greatly exceeds the number of deaths.
Primarily, it is the toxic smoke released by fires that kills or causes
harm by attacking the respiratory systems of humans.
The heat is very painful and can cause severe human injuries for the
rest of a victim's life.
The cost to society is enormous.
Today, fire/flame retardants are frequently applied on commercial products
primarily aimed for the business markets in North America, Europe and
Most of the commercial application products aimed for the business markets
are manufactured in Asia-Pacific.
As mentioned earlier most of these fire retardants are extremely deleterious
to the lives and health of both present and future generations of humans.
MHE® is the prime safe alternative to the harmful chemical fire/flame
retardants that are found in most consumer products made of polymer,
plastic or fibre materials.
Furthermore, the cost of MHE® products makes them very competitive.
In particular MHE® products are market price competitive in metric
tons (MT) in respect of the Chinese market for fire/flame retardant
The global Flame Retardant (FR) market business represents $ 6-7 billion
USD per annum with a market growth of 6.9% annually(2011).
More than 80% ($ 4.8-5.6 billion USD) of the FR business market is outside Europe.
About 48% ($ 2.9-3.4 billion USD) of the global FR business market belongs
In China alone 850,000 metric tons (MT) per annum of FR are applied
on consumer products.
China corresponds to c. 40% ($ 2.4-2.8 USD) of the FR business market
These figures are based on the current average market bulk price in
For example, the most frequently used flame retardant in China is Antimony.
The Antimony bulk price in China (Q3/2011) was $ 13,000 USD per metric
tons (MT) (reported by Roskill Sept 2011).
The Australian Patent Agency - Collison
& Co - in Adelaide, South Australia has made all patent applications
It began in August 2003 [WO 2004/015026 A1] when the first MHE®
patent was filed. Since then it has continued with another MHE®
patent filed in year 2008 [WO 2008122076 A1] and it will be followed
by a number of new MHE® patent product applications during 2017.
Patents for MHE® have been applied for or granted in the following
- All countries in Europe and f.USSR (these patent rights
have been transferred to DeFlamo AB - see earlier in this regard)
- Middle East: Israel
- Africa: South Africa
- Asia-Pacific: China, Hong Kong, Taiwan, Japan,
Korea, Vietnam, Cambodia, Thailand, Malaysia, Singapore, Indonesia
- Asia: India
- Oceania: Australia, New Zealand
- South America: Argentina, Brazil and Chile
- Central America: Mexico
- North America: USA and Canada